Product
Rocakinogene
1 clinical trial
2 indications
Indication
Chronic HepatitisIndication
Hepatitis CClinical trial
Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) InfectionStatus: Active (not recruiting), Estimated PCD: 2020-03-04